百奥泰股价下跌1.37% 全国生物药集采涉及公司3款产品

Group 1 - The stock price of Baiotai closed at 31.00 yuan on August 4, 2025, down by 0.43 yuan, a decrease of 1.37% from the previous trading day [1] - Baiotai is a biopharmaceutical company focused on the research and development of innovative drugs and biosimilars, with key products including Adalimumab and Bevacizumab [1] - The national alliance for biopharmaceuticals has initiated information collection for centralized procurement, involving 8 monoclonal antibody biological agents, with Baiotai having 3 related products in this category [1] Group 2 - The market sales for the 8 biological drugs involved in the procurement have exceeded 28 billion yuan [1] - On August 4, Baiotai experienced a net outflow of main funds amounting to 15.25 million yuan, with a cumulative net outflow of 15.01 million yuan over the past five days [1]